NorwayRats, Inbred BNPicea: A plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta. They are evergreen, pyramidal trees with whorled branches and thin, scaly bark. Each of the linear, spirally arranged leaves is jointed near the stem on a separate woody base.ScandinaviaSvalbardArctic Regions: The Arctic Ocean and the lands in it and adjacent to it. It includes Point Barrow, Alaska, most of the Franklin District in Canada, two thirds of Greenland, Svalbard, Franz Josef Land, Lapland, Novaya Zemlya, and Northern Siberia. (Webster's New Geographical Dictionary, 1988, p66)Seoul virus: A species of HANTAVIRUS causing a less severe form of HEMORRHAGIC FEVER WITH RENAL SYNDROME in Asia (primarily Korea and Japan). It is transmitted by rats, especially Rattus rattus and R. norvegicus.Reindeer: A genus of deer, Rangifer, that inhabits the northern parts of Europe, Asia, and America. Caribou is the North American name; reindeer, the European. They are often domesticated and used, especially in Lapland, for drawing sleds and as a source of food. Rangifer is the only genus of the deer family in which both sexes are antlered. Most caribou inhabit arctic tundra and surrounding arboreal coniferous forests and most have seasonal shifts in migration. They are hunted extensively for their meat, skin, antlers, and other parts. (From Webster, 3d ed; Walker's Mammals of the World, 5th ed, p1397)Salmo salar: A commercially important species of SALMON in the family SALMONIDAE, order SALMONIFORMES, which occurs in the North Atlantic.Fish Diseases: Diseases of freshwater, marine, hatchery or aquarium fish. This term includes diseases of both teleosts (true fish) and elasmobranchs (sharks, rays and skates).Somalia: Somalia is located on the east coast of Africa on and north of the Equator and, with Ethiopia, Eritrea, Djibouti, and Kenya, is often referred to as the Horn of Africa. It comprises Italy's former Trust Territory of Somalia and the former British Protectorate of Somaliland. The capital is Mogadishu.EuropeRegistries: The systems and processes involved in the establishment, support, management, and operation of registers, e.g., disease registers.Rats, Inbred F344IcelandSweden

*  A universal theory of the brain | University of Bergen

The group has done pioneering work in fMRI research in Norway and internationally. ...
uib.no/en/news/90967/universal-theory-brain

*  Head/neck/skin - Dept. of Oncology - Cancer Medicine - Oslo University Hospital Research

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority. Webmaster for research pages: ...
ous-research.no/home/hn/Personell/3562

*  Low faecal carrier rate of vancomycin resistant enterococci in Norwegian hospital patients. | Base documentaire | BDSP

... low level of VRE carriage corresponds to the limited use of glycopeptide antibiotics for human therapeutic purposes in Norway. ...
bdsp.ehesp.fr/Base/181589/

*  Oslo University Hospital Research

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority. Webmaster for research pages: ...
ous-research.no/home/ous/Publications/10933?page=publist&src=&doctype=1,2&extra=i&unitid=1000234&order=year-rev-author&cr=&inpress=0&yearfrom=2016&yearto=2016

*  Arne Yndestad's group - Res Inst of Internal Med - Surg, Inflam. Med. & Transplant - Oslo University Hospital Research

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority. Webmaster for research pages: ...
https://ous-research.no/home/yndestad/Group members/6736

*  Oslo University Hospital Research

Adrenoleukodystrophy in Norway: high rate of de novo mutations and age-dependent penetrance. Pediatr Neurol, 48 (3), 212-9. ... Changes in the prevalence of hypothyroidism: the HUNT Study in Norway. Eur J Endocrinol, 169 (5), 613-20. PubMed 23975540 ... Malignant melanoma--diagnosis, treatment and follow-up in Norway. Tidsskr Nor Laegeforen, 133 (20), 2154-9. PubMed 24172628 ... Does thyroid function influence fracture risk? Prospective data from the HUNT2 study, Norway. Eur J Endocrinol, 169 (6), 845-52 ...
ous-research.no/home/ous/Publications/10933?page=publist&src=&doctype=1,2&extra=i&unitid=1000158&order=year-rev-author&cr=&inpress=0&yearfrom=2013&yearto=2013

*  IEA - Norway

This way, Norway will become a carbon neutral nation - Norway will undertake to reduce global greenhouse gas emissions by the ... Norway intends to cut the global emissions equivalent to 100% of its own emissions within 2030. ... equivalent of 30% of its own 1990 emissions by 2020 - Norway will strengthen its Kyoto commitment by 10 percentage points, ...
iea.org/policiesandmeasures/pams/norway/name-24170-en.php

*  Norway Heritage Community - Norsewood, NZ Norwegian immigrants

I am trying to find anyone with these surnames that may have immigrated to New Zealand from Norway. Apart from information from ...
norwayheritage.com/snitz/topic.asp?TOPIC_ID=940&SearchTerms=,norsewood

*  Oslo University Hospital Research

Toxoplasma prevalence among pregnant women in Norway: a cross-sectional study. APMIS, 123 (4), 321-5. PubMed 25628065 ... Persistent Low Toxoplasma IgG Avidity Is Common in Pregnancy: Experience from Antenatal Testing in Norway. PLoS One, 10 (12), ... Two cases of acute severe flaccid myelitis associated with enterovirus D68 infection in children, Norway, autumn 2014. Euro ... Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority. Webmaster for research pages: ...
ous-research.no/home/ous/Publications/10933?page=publist&src=&doctype=1,2&extra=i&unitid=1000171&order=year-rev-author&cr=&inpress=0&yearfrom=2015&yearto=2015

*  Oslo University Hospital Research

High prevalence and no latitude gradient of multiple sclerosis in Norway. Mult Scler, 20 (13), 1780-2. PubMed 24603884 ... Aicardi syndrome: an epidemiologic and clinical study in Norway. Pediatr Neurol, 52 (2), 182-6.e3. PubMed 25443581 ... Duties performed by occupational physicians in Norway. Occup Med (Lond), 65 (2), 139-42. PubMed 25548257 ... Prevalence of multiple sclerosis among immigrants in Norway. Mult Scler, 21 (6), 695-702. PubMed 25344371 ...
ous-research.no/home/ous/Publications/10933?page=publist&src=&doctype=1,2&extra=i&unitid=1000151&order=year-rev-author&cr=&inpress=0&yearfrom=2014&yearto=2014

*  Share the page

Tore Renberg was born on August 3, 1972 in Stavanger, Rogaland, Norway. He is a writer and actor, known for Mannen som elsket ... Tore Renberg was born on August 3, 1972 in Stavanger, Rogaland, Norway. He is a writer and actor, known for Mannen som elsket ...
imdb.com/name/nm1123929/

*  Oslo University Hospital Research

Trends in Abdominal Aortic and Iliac Aneurysm Repairs in Norway from 2001 to 2013. Eur J Vasc Endovasc Surg, 51 (2), 194-201. ... Lung cancer survival in Norway, 1997-2011: from nihilism to optimism. Eur Respir J, 47 (1), 275-87. PubMed 26541525 ... Indications and Outcomes in Liver Transplantation in Patients With Primary Sclerosing Cholangitis in Norway. Transplant Direct ... Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority. Webmaster for research pages: ...
ous-research.no/home/ous/Publications/10933?page=publist&src=&doctype=1,2&extra=i&unitid=1000155&order=year-rev-author&cr=&inpress=0&yearfrom=2015&yearto=2015

*  New Zealand - OECD

Norway) ... Norway) Related Documents. * Taking Fear out of Schools - ...
oecd.org/edu/innovation-education/bycountry/newzealand/

*  Flights to Stavanger, Norway - KLM.com

A visit to the fascinating Norwegian Petroleum Museum will illustrate why Stavanger is the oil capital of Norway. It is also ... Add in our many handy extra services (some available for a supplement) and you'll be in Norway before you know it. ... Stavanger is not only perfect for a city trip but also makes a great starting point for a longer holiday in Norway. Expect to ...
https://klm.com/destinations/ao/en/europe/norway/stavanger

*  Chernobyl fallout : internal doses to the Norwegian population and the effect of dietary advice. | Base documentaire | BDSP

... were used to estimate the intake of radiocesium and the radiation dose received by different groups of people in Norway after ... Mots-cl s Pascal anglais : Feeding, Radioactive contamination, Cesium, Radioisotope, Norway, Europe, Ukraine, USSR, Accident, ... were used to estimate the intake of radiocesium and the radiation dose received by different groups of people in Norway after ...
bdsp.ehesp.fr/Base/62461/

*  Oslo University Hospital Research

Prevalence of Thyroid Dysfunction in Autoimmune and Type 2 Diabetes: The Population-Based HUNT Study in Norway. J Clin ... Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority. Webmaster for research pages: ...
ous-research.no/home/ous/Publications/10933?page=publist&src=&doctype=1,2&extra=i&unitid=1000174&order=year-rev-author&cr=&inpress=0&yearfrom=2015&yearto=2015

*  F. L. Jahnsen - Pathology - Laboratory Medicine - Oslo University Hospital Research

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority. Webmaster for research pages: ...
ous-research.no/home/jahnsen/Group members/13083

*  Dept. of Oncology - Cancer Medicine - Oslo University Hospital Research

A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer ... Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority. Webmaster for research pages: ...
ous-research.no/home/oncology/Group members/3249

*  Ocular findings in Norwegian patients with ataxia-telangiectasia: a 5 year prospective cohort study - Riise - 2007 - Acta...

The study was approved by the Regional Scientific Ethical Committee of East Norway and was conducted in accordance with the ... Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, Norway ... Norway. Tel: + 47 62 52 40 61. Fax: +47 62 53 79 65. Email: ruthr@online.no ...
onlinelibrary.wiley.com/doi/10.1111/j.1600-0420.2007.00890.x/full

*  Health consequences of reduced daily cigarette consumption | Tobacco Control

Setting: Three counties in Norway.. Participants: 24 959 men and 26 251 women, aged 20-49 years, screened for risk factors of ... 2National Health Screening Service, Oslo, Norway. *Correspondence to: K Bjartveit Fridtjof Nansens vei 24 B, N-0369 Oslo, ... Bjartveit K, Wøien G. Cardiovascular disease risk factors in Norway. Results from surveys in 18 counties. Oslo: Statens ... 1Norwegian Institute of Public Health, Oslo, Norway. *. ...
tobaccocontrol.bmj.com/content/15/6/472

*  IBM Commerce - Norway

Learn how IBM can help you know what your customer wants, before they do, using Cognitive Commerce.
https://ibm.com/commerce/no-en/?re=spf

*  Norway: Oslo | Flickr

Explore this photo album by Multerland......... on Flickr!
https://flickr.com/photos/antoinettejanssen/sets/72157627978001246/

*  VMware Support | Norway

VMware delivers virtualization benefits via virtual machine, virtual server, and virtual pc solutions.
https://vmware.com/be/support/contacts/norway.html

*  My norway trip

Siim UmerovKadrina keskkool
https://slideshare.net/merikekk/my-norway-trip

Hospital of Southern Norway: [[Sørlandet Hospital Arendal, seen from the north.|thumb|200px]]AstringinGuksiTemplet (Svalbard): Templet is a mountain north of Sassenfjorden, at the south side of Bünsow Land at Spitsbergen, Svalbard. Its height is 766 metre.Circumpolar Health Bibliographic DatabaseSeoul virus: Seoul virus (SEOV) is a species of hantavirus that can cause a form of hemorrhagic fever.The White ReindeerEuropean Community Reference Laboratory for Fish Diseases: The European Community Reference Laboratory for Fish DiseasesCommunity Reference Laboratory for Fish Diseases is located in Frederiksberg in Denmark at the National Veterinary Institute (a part of Technical University of Denmark).Transport in Somalia: Transport in Somalia refers to the transportation networks and modes of transport in effect in Somalia. They include highways, airports and seaports, in addition to various forms of public and private vehicular, maritime and aerial transportation.GA²LENDisease registry: Disease or patient registries are collections of secondary data related to patients with a specific diagnosis, condition, or procedure, and they play an important role in post marketing surveillance of pharmaceuticals. Registries are different from indexes in that they contain more extensive data.Iceland–Russia relationsClimate change in Sweden: The issue of climate change has received significant public and political attention in Sweden and the mitigation of its effects has been high on the agenda of the two latest Governments of Sweden, the previous Cabinet of Göran Persson (-2006) and the current Cabinet of Fredrik Reinfeldt (2006-). Sweden aims for an energy supply system with zero net atmospheric greenhouse gas emissions by 2050.

(1/3226) Reproductive factors and fatal hip fractures. A Norwegian prospective study of 63,000 women.

STUDY OBJECTIVE: The aim of the study was to investigate the impact of reproductive variables (age at menarche, menopause, first and last birth as well as parity, lactation, and abortions) on hip fracture mortality. DESIGN AND SETTING: A prospective study in Norway with more than 60,000 women followed up for 29 years. A total of 465 deaths as a result of hip fracture were recorded. MAIN RESULTS: Statistically significant linear relations (p < or = 0.02) were found between both age at menarche and length of reproductive period (defined as age at menopause to age at menarche) and the mortality of hip fractures in women aged less than 80. The death rate for women with a late menarche (> or = 17 years) was twice that of the women with relatively early menarche (< or = 13 years). Compared with women with less than 30 years between menopause and menarche, the mortality rate ratio in women with more than 38 reproductive years was 0.5. We also found an inverse relation with age at first birth. CONCLUSIONS: This study supports by hypothesis that an early menarche and a long reproductive period protect against hip fracture mortality. High age at first birth may also be protective.  (+info)

(2/3226) Exposure to nitrogen dioxide and the occurrence of bronchial obstruction in children below 2 years.

BACKGROUND: The objective of the investigation was to test the hypothesis that exposure to nitrogen dioxide (NO2) has a causal influence on the occurrence of bronchial obstruction in children below 2 years of age. METHODS: A nested case-control study with 153 one-to-one matched pairs was conducted within a cohort of 3754 children born in Oslo in 1992/93. Cases were children who developed > or = 2 episodes of bronchial obstruction or one episode lasting >4 weeks. Controls were matched for date of birth. Exposure measurements were performed in the same 14-day period within matched pairs. The NO2 exposure was measured with personal samplers carried close to each child and by stationary samplers outdoors and indoors. RESULTS: Few children (4.6%) were exposed to levels of NO2 > or = 30 microg/m3 (average concentration during a 14-day period). In the 153 matched pairs, the mean level of NO2 was 15.65 microg/m3 (+/-0.60, SE) among cases and 15.37 (+/-0.54) among controls (paired t = 0.38, P = 0.71). CONCLUSIONS: The results suggest that NO2 exposure at levels observed in this study has no detectable effect on the risk of developing bronchial obstruction in children below 2 years of age.  (+info)

(3/3226) Salmonella infections in Norway: descriptive epidemiology and a case-control study.

The epidemiological progression of human salmonellosis in Norway is parallel to trends noted elsewhere in Europe. During the past two decades, the number of reported cases has increased steadily, with a special sharp rise in the early 1980s due to the emergence of Salmonella enteritidis, followed by a levelling off in recent years. However, in contrast to the situation in most other European countries, about 90% of the cases from whom a travel history is available, have acquired their infection abroad. The incidence of indigenous salmonella infections as well as the prevalence of the microorganism in the domestic food chain, are both comparatively low. In 1993-4, a national case-control study of sporadic indigenous salmonella infections was conducted to identify preventable risk factors and guide preventive efforts. Ninety-four case patients and 226 matched population controls were enrolled. The study failed to demonstrate any statistically significant association between salmonellosis and consumption of domestically produced red meat, poultry or eggs. The only factor which remained independently associated with an increased risk in conditional logistic regression analysis, was consumption of poultry purchased abroad during holiday visits to neighbouring countries. A separate analysis of Salmonella typhimurium infections incriminated food from catering establishments and foreign travel among household members, in addition to imported poultry.  (+info)

(4/3226) Homozygosity mapping to the USH2A locus in two isolated populations.

Usher syndrome is a group of autosomal recessive disorders characterised by progressive visual loss from retinitis pigmentosa and moderate to severe sensorineural hearing loss. Usher syndrome is estimated to account for 6-10% of all congenital sensorineural hearing loss. A gene locus in Usher type II (USH2) families has been assigned to a small region on chromosome 1q41 called the UHS2A locus. We have investigated two families with Usher syndrome from different isolated populations. One family is a Norwegian Saami family and the second family is from the Cayman Islands. They both come from relatively isolated populations and are inbred families suitable for linkage analysis. A lod score of 3.09 and 7.65 at zero recombination was reached respectively in the two families with two point linkage analysis to the USH2A locus on 1q41. Additional homozygosity mapping of the affected subjects concluded with a candidate region of 6.1 Mb. This region spans the previously published candidate region in USH2A. Our study emphasises that the mapped gene for USH2 is also involved in patients from other populations and will have implications for future mutation analysis once the USH2A gene is cloned.  (+info)

(5/3226) Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness.

Exhaled nitric oxide is a potential marker of lower airway inflammation. Allergic rhinitis is associated with asthma and bronchial hyperresponsiveness. To determine whether or not nasal and exhaled NO concentrations are increased in allergic rhinitis and to assess the relation between hyperresponsiveness and exhaled NO, 46 rhinitic and 12 control subjects, all nonasthmatic nonsmokers without upper respiratory tract infection, were randomly selected from a large-scale epidemiological survey in Central Norway. All were investigated with flow-volume spirometry, methacholine provocation test, allergy testing and measurement of nasal and exhaled NO concentration in the nonpollen season. Eighteen rhinitic subjects completed an identical follow-up investigation during the following pollen season. Exhaled NO was significantly elevated in allergic rhinitis in the nonpollen season, especially in perennially sensitized subjects, as compared with controls (p=0.01), and increased further in the pollen season (p=0.04), mainly due to a two-fold increase in those with seasonal sensitization. Nasal NO was not significantly different from controls in the nonpollen season and did not increase significantly in the pollen season. Exhaled NO was increased in hyperresponsive subjects, and decreased significantly after methacholine-induced bronchoconstriction, suggesting that NO production occurs in the peripheral airways. In allergic rhinitis, an increase in exhaled nitric oxide on allergen exposure, particularly in hyperresponsive subjects, may be suggestive of airway inflammation and an increased risk for developing asthma.  (+info)

(6/3226) Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35.

PURPOSE: The aim of this study was to define the scales and test the validity, reliability, and sensitivity of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ)-H&N35, a questionnaire designed to assess the quality of life of head and neck (H&N) cancer patients in conjunction with the general cancer-specific EORTC QLQ-C30. PATIENTS AND METHODS: Questionnaires were given to 500 H&N cancer patients from Norway, Sweden, and the Netherlands as part of two prospective studies. The patients completed the questionnaires before, during (Norway and Sweden only), and after treatment, yielding a total of 2070 completed questionnaires. RESULTS: The compliance rate was high, and the questionnaires were well accepted by the patients. Seven scales were constructed (pain, swallowing, senses, speech, social eating, social contact, sexuality). Scales and single items were sensitive to differences between patient subgroups with relation to site, stage, or performance status. Most scales and single items were sensitive to changes, with differences of various magnitudes according to the site in question. The internal consistency, as assessed by Cronbach's alpha coefficient, varied according to assessment point and within subsamples of patients. A low overall alpha value was found for the speech and the senses scales, but values were higher in assessments of patients with laryngeal cancer and in patients with nose, sinus, and salivary gland tumors. Scales and single items in the QLQ-H&N35 seem to be more sensitive to differences between groups and changes over time than do the scales and single items in the core questionnaire. CONCLUSION: The QLQ-H&N35, in conjunction with the QLQ-C30, provides a valuable tool for the assessment of health-related quality of life in clinical studies of H&N cancer patients before, during, and after treatment with radiotherapy, surgery, or chemotherapy.  (+info)

(7/3226) Reduced health-related quality of life among Hodgkin's disease survivors: a comparative study with general population norms.

BACKGROUND: Late complications after curative treatment of Hodgkin's disease are of special relevance because most of the cured are young adults. The aims of the present study were: (1) to compare health-related quality of life (HRQOL) in Hodgkin's disease (HD) survivors with normative data from the general Norwegian population and (2) to examine the relations between disease/treatment characteristics and HRQOL in the HD survivors. PATIENTS AND METHODS: 459 HD survivors aged 19-74 years (mean 44.0, SD 11.8) treated at the Norwegian Radium Hospital 1971-1991 were approached in 1994 and compared to norms from 2214 subjects approached in 1996. The norms are representative of the general Norwegian population. HRQOL was assessed by the Short Form 36 (SF-36), which measures HRQOL in eight separate scales (0 = worst health state, 100 = best health state). RESULTS: The HD survivors had lower scores than the normal controls on all scales after adjustment for age, gender and educational levels. Statistically significant differences (P < 0.01) were found in general health (10.4), physical functioning (6.1), role limitations (physical, 9.3), physical functioning (3.6) and in vitality (4.7). Patients with disease stage IB-IIB had the lowest scores on all scales. The differences in relation to stage/substage reached statistical significance (P < 0.01) in physical functioning and in role limitations (physical). Time since diagnosis, types of primary treatment or having relapsed were not associated with statistically significant differences in HRQOL. CONCLUSION: Long-term HD survivors have poorer HRQOL, primarily in physical health, than the general Norwegian population.  (+info)

(8/3226) Relative virulence of three isolates of Piscirickettsia salmonis for coho salmon Oncorhynchus kisutch.

Piscirickettsia salmonis was first recognized as the cause of mortality among pen-reared coho salmon Oncorhynchus kisutch in Chile. Since the initial isolation of this intracellular Gram-negative bacterium in 1989, similar organisms have been described from several areas of the world, but the associated outbreaks were not reported to be as serious as those that occurred in Chile. To determine if this was due to differences in virulence among isolates of P. salmonis, we conducted an experiment comparing isolates from Chile, British Columbia, Canada, and Norway (LF-89, ATL-4-91 and NOR-92, respectively). For each of the isolates, 3 replicates of 30 coho salmon were injected intraperitoneally with each of 3 concentrations of the bacterium. Negative control fish were injected with MEM-10. Mortalities were collected daily for 41 d post-injection. Piscirickettsiosis was observed in fish injected with each of the 3 isolates, and for each isolate, cumulative mortality was directly related to the concentration of bacterial cells administered. The LF-89 isolate was the most virulent, with losses reaching 97% in the 3 replicates injected with 10(5.0) TCID50, 91% in the replicates injected with 10(4.0) TCID50, and 57% in the fish injected with 10(3.0) TCID50. The ATL-4-91 isolate caused losses of 92% in the 3 replicates injected with 10(5.0) TCID50, 76% in the fish injected with 10(4.0) TCID50, and 32% in those injected with 10(3.0) TCID50. The NOR-92 isolate was the least virulent, causing 41% mortality in the replicates injected with 10(4.6) TCID50. At 41 d post-injection, 6% of the fish injected with 10(3.6) TCID50 NOR-92 had died. Mortality was only 2% in the fish injected with 10(2.6) TCID50 NOR-92, which was the same as the negative control group. Because the group injected with the highest concentration (10(4.6) TCID50) of NOR-92 was still experiencing mortality at 41 d, it was held for an additional 46 d. At 87 d post-injection, the cumulative mortality in this group had reached 70%. These differences in virulence among the isolates were statistically significant (p < 0.0001), and are important for the management of affected stocks of fish.  (+info)



Agreement


  • The agreement implies that more than three quarters of the members of the Norwegian Parliament support an ambitious climate change policy: - Norway intends to cut the global emissions equivalent to 100% of its own emissions within 2030. (iea.org)

Member


  • Norway is not a member of the European Union and is not obligated to follow the EC WEEE Directive. (corning.com)